Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease
| Title: | Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease |
|---|---|
| Authors: | Yale JF; Bakris G; Cariou B; Nieto J; David Neto E; Yue D; Wajs E; Figueroa K; Jiang J; Law G; Usiskin K; Meininger G; DIA3004 Study Group; Ansari A; Arnouts P; Assefi A; Barreto A; Barysheva O; Bavanandam S; Blaze K; Bochenek A; Bononi P; Booth W; Boyarkin M; Burgess L; Busch K; Buse J; Carranza J; Cha B; Chang A; Clavel S; Cockrell RC; Conway J; Cook W; Dande A; De Los Rios MO; Deshmukh V; Dobjanschi C; DOTTA, FRANCESCO; Elliott T; Ellis G; Ferraro R; Fishman N; Fomin V; Fraige Filho F; Gagiu R; Goh BL; Goldenberg R; Gorriz JL; Gottschlich G; Gouet D; Grenfell R; Griffin C; Guarisco M; Guerci B; Henkel E; Hramiak I; Ison R; Jadoul M; Jang H; Januszewicz A; Kale S; Karpova I; Kaye W; Kerstein H; Kijanska J; Kobalava Z; Kong N; Krasilnikova E; Krebs J; Kuczerowski R; Kuzin A; Kuzmenko A; Laurens W; Lim SK; Marasaev V; Castelao AM; Merker L; Michlin B; Morales E; Motylev I; Muse D; Mutha A; Neto ED; Nicholls K; Niemetz I; Iglesias JN; Ong LM; Onor G; Packham D; Petit C; Piatti M; Pirags V; Poch E; Ramirez G; Riser J; Roger S; Ross S; Rudolph L; Sangumani J; Schollum J; Scott R; Sebopa B; Serafinceanu C; Serusclat P; Seufert J; Siegmund T; Silva A; Skokowska E; Smith D; Sokolova J; Solovyov O; Steindorf J; Stringam S; Teterovska D; Thivolet C; Tytus R; Vally T; Van Vlem B; Vercammen C; Volkova N; Warling X; Winkler L; Young S; Zanella MT; Zimmerer M. |
| Contributors: | Yale, Jf; Bakris, G; Cariou, B; Nieto, J; David Neto, E; Yue, D; Wajs, E; Figueroa, K; Jiang, J; Law, G; Usiskin, K; Meininger, G; DIA3004 Study, Group; Ansari, A; Arnouts, P; Assefi, A; Barreto, A; Barysheva, O; Bavanandam, S; Blaze, K; Bochenek, A; Bononi, P; Booth, W; Boyarkin, M; Burgess, L; Busch, K; Buse, J; Carranza, J; Cha, B; Chang, A; Clavel, S; Cockrell, Rc; Conway, J; Cook, W; Dande, A; De Los Rios, Mo; Deshmukh, V; Dobjanschi, C; Dotta, Francesco; Elliott, T; Ellis, G; Ferraro, R; Fishman, N; Fomin, V; Fraige Filho, F; Gagiu, R; Goh, Bl; Goldenberg, R; Gorriz, Jl; Gottschlich, G; Gouet, D; Grenfell, R; Griffin, C; Guarisco, M; Guerci, B; Henkel, E; Hramiak, I; Ison, R; Jadoul, M; Jang, H; Januszewicz, A; Kale, S; Karpova, I; Kaye, W; Kerstein, H; Kijanska, J; Kobalava, Z; Kong, N; Krasilnikova, E; Krebs, J; Kuczerowski, R; Kuzin, A; Kuzmenko, A; Laurens, W; Lim, Sk; Marasaev, V; Castelao, Am; Merker, L; Michlin, B; Morales, E; Motylev, I; Muse, D; Mutha, A; Neto, Ed; Nicholls, K; Niemetz, I; Iglesias, Jn; Ong, Lm; Onor, G; Packham, D; Petit, C; Piatti, M; Pirags, V; Poch, E; Ramirez, G; Riser, J; Roger, S; Ross, S; Rudolph, L |
| Publication Year: | 2014 |
| Collection: | Università degli Studi di Siena: USiena air |
| Subject Terms: | Diabetic nephropathy; Randomized trial; Sodium glucose co-transporter 2 (SGLT2) inhibitor; Type 2 diabetes mellitus |
| Description: | Aim: This study evaluated the efficacy and safety of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus (T2DM) and within a subset of Stage 3 chronic kidney disease (CKD; estimated glomerular filtration rate [eGFR] ≥30 and |
| Document Type: | article in journal/newspaper |
| File Description: | STAMPA |
| Language: | English |
| Relation: | info:eu-repo/semantics/altIdentifier/pmid/24965700; info:eu-repo/semantics/altIdentifier/wos/WOS:000342925200018; volume:16; issue:10; firstpage:1016; lastpage:1027; numberofpages:12; journal:DIABETES, OBESITY AND METABOLISM; http://hdl.handle.net/11365/49426 |
| DOI: | 10.1111/dom.12348 |
| Availability: | http://hdl.handle.net/11365/49426; https://doi.org/10.1111/dom.12348; https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.12348 |
| Rights: | info:eu-repo/semantics/closedAccess |
| Accession Number: | edsbas.54CBEB15 |
| Database: | BASE |